133 results
Page 2 of 7
425
r4eis5y7gf34o9f2bnp
22 May 23
Business combination disclosure
7:01am
8-K
q9rzhwb1vd47xh3tm
22 May 23
Other Events
6:59am
8-K
EX-99.1
v8cmdp6rpcbedg u1v9m
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
i3vuee
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
g9569d 3qbx
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
wk7yuezgr dzcsy
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-99.1
550c1t0y31
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
8-K
gaw0e
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
k9dahb1xgf0qjbayl
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am